SportsMap Tech Acquisition (SMAPW) Competitors $0.06 0.00 (0.00%) As of 04/25/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock SMAPW vs. HTGMQ, OLITW, PRENW, QSIAW, TT, KEYS, FTV, VLTO, TER, and RVTYShould you be buying SportsMap Tech Acquisition stock or one of its competitors? The main competitors of SportsMap Tech Acquisition include HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), Trane Technologies (TT), Keysight Technologies (KEYS), Fortive (FTV), Veralto (VLTO), Teradyne (TER), and Revvity (RVTY). These companies are all part of the "measuring and control equipment" industry. SportsMap Tech Acquisition vs. HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si Trane Technologies Keysight Technologies Fortive Veralto Teradyne Revvity SportsMap Tech Acquisition (NASDAQ:SMAPW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends, media sentiment and community ranking. Does the media prefer SMAPW or HTGMQ? In the previous week, SportsMap Tech Acquisition's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score. Company Overall Sentiment SportsMap Tech Acquisition Neutral HTG Molecular Diagnostics Neutral Which has preferable valuation and earnings, SMAPW or HTGMQ? SportsMap Tech Acquisition has higher earnings, but lower revenue than HTG Molecular Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSportsMap Tech AcquisitionN/AN/AN/AN/AN/AHTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A Does the MarketBeat Community believe in SMAPW or HTGMQ? SportsMap Tech Acquisition and HTG Molecular Diagnostics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformSportsMap Tech AcquisitionN/AN/AHTG Molecular DiagnosticsN/AN/A Is SMAPW or HTGMQ more profitable? Company Net Margins Return on Equity Return on Assets SportsMap Tech AcquisitionN/A N/A N/A HTG Molecular Diagnostics N/A N/A N/A SummaryHTG Molecular Diagnostics beats SportsMap Tech Acquisition on 1 of the 1 factors compared between the two stocks. Get SportsMap Tech Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for SMAPW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMAPW vs. The Competition Export to ExcelMetricSportsMap Tech AcquisitionShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$348.89M$3.84B$7.82BDividend YieldN/A5.35%4.21%4.22%P/E RatioN/A0.5313.0418.48Price / SalesN/A483.261,689.09103.91Price / CashN/A178.7350.4934.62Price / BookN/A92.043.414.25Net IncomeN/A-$141.08M$1.25B$248.23M7 Day PerformanceN/A0.50%1.58%3.29%1 Month PerformanceN/A35.53%12.98%2.42%1 Year PerformanceN/A19.79%13.05%5.54% SportsMap Tech Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMAPWSportsMap Tech AcquisitionN/A$0.06flatN/AN/A$0.00N/A0.00N/AHTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.04+43.3%N/A-71.8%$0.00N/A0.003High Trading VolumePRENWPrenetics GlobalN/A$0.01flatN/A+24.0%$0.00$25.56M0.001Short Interest ↓Gap DownQSIAWQuantum-SiN/A$0.38+14.2%N/A+52.2%$0.00$3.06M0.00150Positive NewsGap UpTTTrane Technologies3.9499 of 5 stars$336.38+1.1%$405.31+20.5%+20.8%$75.45B$19.84B29.9039,000Earnings ReportPositive NewsGap UpKEYSKeysight Technologies4.1982 of 5 stars$137.52+1.8%$181.33+31.9%-1.7%$23.76B$5.02B39.2915,000Short Interest ↑Analyst RevisionPositive NewsFTVFortive4.6256 of 5 stars$67.16+1.8%$81.92+22.0%-7.4%$22.85B$6.23B28.4618,000Positive NewsVLTOVeralto2.9421 of 5 stars$90.61+1.6%$111.10+22.6%+2.5%$22.12B$5.19B27.1316,000Earnings ReportShort Interest ↑Positive NewsTERTeradyne4.9293 of 5 stars$73.22+2.7%$118.94+62.4%-36.2%$11.78B$2.82B21.996,500Earnings ReportAnalyst ForecastBuyback AnnouncementOptions VolumePositive NewsRVTYRevvity3.8745 of 5 stars$93.73+1.5%$130.50+39.2%-8.9%$11.26B$2.76B42.4116,700Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews Coverage Related Companies and Tools Related Companies HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors Trane Technologies Competitors Keysight Technologies Competitors Fortive Competitors Veralto Competitors Teradyne Competitors Revvity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMAPW) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SportsMap Tech Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share SportsMap Tech Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.